Maggu AI, a Brazilian startup specializing in artificial intelligence applied to the pharmaceutical retail sector, announces a new investment round of R$ 22 million, bringing its total raised since its founding to over R$ 28 million. The round was led by DGF Investimentos, with participation from Norte Ventures, Latitud, IC Ventures, and Airborne Ventures. With this investment, the company is now valued at R$ 138 million.
Founded by Felipe Trevisan and Luiz Andrade, and co-founded by Pedro Magela, Reslley Gabriel, and Rérica Lins—entrepreneurs with a history of creating and selling startups to companies like Rappi, Infracommerce, and Shopper—Maggu developed a digital infrastructure integrated with pharmacy management systems that uses artificial intelligence to support counter service, one of the most critical moments in the consumer journey.
In practice, the system functions as an AI co-pilot for the pharmacy team, supporting real-time decision-making at the counter and strengthening pharmaceutical care. For example, when assisting a customer seeking treatment for severe acne, the attendant receives relevant usage and care instructions—such as avoiding sun exposure and using appropriate protective products. This makes dispensing safer and more consistent for the patient and can increase the sale of complementary items when appropriate.
Inside pharmacies, attendants deal daily with thousands of items – prescription and non-prescription medications, hygiene and beauty products, tests, and health services – in a context of high staff turnover and systems that are often still purely transactional. “Maggu was created to solve a structural problem in the pharmaceutical retail sector: the enormous complexity of customer service, with little technological support at the point of decision,” says Felipe Trevisan, founding partner of the company.
The executive also highlights that the pharmaceutical retail sector in Latin America is one of the most fragmented in the world, in a region that concentrates around 270,000 pharmacies, with more than 90,000 in Brazil alone, a number higher than that of markets like the United States. "This widespread presence makes the pharmacy the population's first point of contact with the healthcare system, even before clinics or hospitals, but it also makes the sector highly fragmented and difficult to scale from an operational standpoint," he explains.
Today, Maggu is present in 17,500 pharmacies connected through system integration. Of this total, 2,200 stores are already actively operating the platform, while the others are in the technical activation and rollout phase. With a national presence, the company primarily serves independent pharmacies and small and medium-sized chains. Maggu acts as an embedded intelligence layer in the service flow, raising the standard of decision-making at the counter and the quality of the consumer journey.
The funds raised will be used to expand the network of integrated pharmacies, advance the application of artificial intelligence to customer service, strengthen the startup's technology, and grow the team. With over 1.6 million products registered in its database and direct integration with pharmacies' operating systems, Maggu is establishing itself as an essential infrastructure for the Brazilian pharmaceutical retail sector.
